Amgen (AMGN)/Data

Amgen (AMGN)

SUMMARY

BULLS

BEARS

Loading ...

Key Metrics for AMGN as compared to

All values TTM unless otherwise noted (*)

STOCK SUMMARY

Open	52.65
Day Range	52.69-51.46
52 Week Range	27.00-66.51
Volume	7.57M
Avg Volume (3 mo)	7.68M
Shares Outstanding	1.01B
Market Cap	52.1B

INDUSTRY METRICS (See all)

Revenue ►	14.7B	HIGH
R&D Expense ►	3.03B	AVG
R&D/Sales Ratio ►	20.2%	HIGH
Number of Drugs in Phase I ►	13.0	AVG
Number of Drugs in Phase II ►	14.0	LOW
Number of Drugs in Phase III ►	10.0	AVG
Gross Margin ►	84.7%

INCOME STATEMENT (See all)

Revenue ►	14.7B	HIGH
EBITDA ►	6.83B	AVG
Net Income ►	4.08B	AVG
Revenue Growth ►	0%	AVG
Net Income Growth ►	27.8%	AVG
Operating Margin ►	39.7%	AVG
Net Margin ►	27.8%	AVG

BALANCE SHEET (most recent quarter) (See all)

Debt / Equity ►	0.872	AVG
Current Ratio ►	3.44	AVG
Quick Ratio ►	3.00	AVG
Interest Coverage Ratio ►	13.1	AVG
Book Value Per Share ►	19.7
Cash Per Share ►	2.74

FEATURED: INTERACTIVE DATA

VALUATION

Price to Earnings (P/E) ►	13.2	AVG
Price to Book (P/B) ►	2.69	AVG
Price to Sales (P/S) ►	3.66	AVG
Return on Assets (ROA) ►	12.2%	AVG
Return on Equity (ROE) ►	20.9%	AVG
EV/EBITDA ►	9.80	AVG
Dividend Yield	0%	AVG

ANALYST RECOMMENDATIONS

OWNERSHIP

Net Insider Buying 3mo	-7.6%
Net Insider Buying 6mo	-10.6%
Net Insider Buying 1yr	-21.4%
Held by insiders	0.3%
Held by institutions	63.5%

Income Statement

Data Sources:

Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.

Worried about pump and dump?

We review changes
for stock spam

» read more

Want to make Wikinvest better?

We need your help,
contribute today

» learn how

Do you write software?

We are recruiting
the best engineers

» view jobs

Like Wikinvest?

Spread the word —
Tell your friends!

» spread the word

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.